Skip to content
#gene editing Open access

Nigral DJ-1 gene knockout in tree shrews can induce phosphorylated α-synuclein aggregation and all key phenotypes of Parkinson’s disease

Aug 2026 · Cell Death & Disease · 0 citations
Parkinson's Disease Mechanisms and Treatments

TL;DR

In vivo evidence is provided supporting a model in which DJ-1 deficiency can promote key PD-like phenotypes in tree shrews, potentially involving PSer129αSyn accumulation, nigral dopaminergic neuron loss, and motor dysfunction.

Abstract

DJ-1 is a genetic factor associated with Parkinson’s disease (PD), and altered DJ-1 function has been implicated in PD pathogenesis. However, DJ-1 knockout mice fail to reproduce robust PD-like phenotypes or neuropathology, leaving the contribution of DJ-1 deficiency to PD-related disease processes unresolved. To investigate this question in a species more closely related to primates than rodents, we used the tree shrew and performed bilateral, neuron-targeted DJ-1 knockout in the substantia nigra using an AAV-mediated in situ gene editing system. Four out of five DJ-1 knockout tree shrews developed key PD features, including motor abnormalities, substantial loss of nigral dopaminergic neurons, and aggregation of phosphorylated α-synuclein at serine 129 (PSer129αSyn). Notably, one DJ-1 knockout animal did not develop these phenotypes, despite comparable AAV transduction efficiency and DJ-1 knockout levels in the substantia nigra, suggesting that DJ-1 loss may not be solely sufficient in all cases and that additional modifying or compensatory factors may influence disease manifestation. Further pathological analysis showed that PSer129αSyn aggregation was associated with the development of PD-like phenotypes in this model. These findings support a model in which DJ-1 deficiency can promote key PD-like phenotypes in tree shrews, potentially involving PSer129αSyn accumulation, nigral dopaminergic neuron loss, and motor dysfunction. Given that multiple molecular pathways have been proposed to link DJ-1 dysfunction to PD, our results provide in vivo evidence supporting PSer129αSyn aggregation as an important pathological process associated with DJ-1 deficiency. This tree shrew model may therefore provide a useful experimental platform for studying DJ-1-related PD pathogenesis and evaluating potential therapeutic strategies.

Read PDF

Similar papers

Open access Sep 2026

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson’s disease

PrPC expression levels are identified as an important modulator of nigrostriatal vulnerability and neuroinflammatory phenotype in response to αSynO, supporting the hypothesis that PrPC contributes to αSynO-mediated pathogenic mechanisms.

Flavio de Souza Júnyor, F. Leser, Sarah de Souza Albuquerque et al. · 0 citations
Open access Aug 2026

An atfs-1 loss-of-function screen identifies novel regulators of α-synuclein toxicity in C. elegans dopaminergic neurons

Results provide evidence that jmjd-1.2 and jmjd-3.1 naturally confer protection from α-syn-induced neurotoxicity, and are used to examine the association of these gene products in DA neurodegeneration.

Karolina Willicott, Joy D. Iroegbu, Madeline R. Greene et al. · 0 citations
Open access Sep 2026

Parkinson’s disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35

A comprehensive evaluation of the VPS35 protein interactome is provided and a selective effect of the PD-linked D620N mutation in mammalian cells and brain is revealed, providing key insight into the mechanisms of retromer dysfunction in VPS35-linked PD.

Erin T. Williams, Maxwell Frye, Xi Chen et al. · 0 citations
Open access Sep 2026

Label-Free Proteomics of α-Synuclein-Expressing Caenorhabditis elegans Model Uncovers Conserved Pathophysiological Pathways in Parkinson’s Disease

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease in the elderly population, characterized by a wide variety of motor and non-motor symptoms. Its complex biochemical and molecular mechanisms make it challenging to study PD directly in patients or to replicate it in vitro, underscoring the...

Iverson Conrado Bezerra, Maria Luiza de Lima Vitorino, Josivan Barbosa de Farias et al. · 0 citations

Related blog posts

Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.